WWW.LIVESCIENCE.COM
Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
0 Comentários 0 Compartilhamentos 17 Visualizações